Spotlight on Endometrial Cancer: Breakthroughs & Concerns
Recorded on May 14, 2021
Sponsored by GSK

This Virtual Global Patient Perspectives Roundtable—focused on Endometrial Cancer —is the second in a series of four roundtables sponsored by GSK.

These topics are relevant to patient care and outcomes, options, and autonomy and are especially significant in the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information across populations, specialties, and regions, attendees will enhance their understanding of these important topics and be more empowered to exercise their rights and options related to each.


Lucy Gilbert, MD, MSc, FRCOG
Professor, Department of Obstetrics and Gynecology and Department of Oncology, McGill University; Director, Division of Gynecologic Oncology, McGill University Health Center; Director, Women's Health Research Unit; Research Institute - McGill University Health Center; Creator, DOvE (Diagnosing Ovarian and Endometrial Cancers Early)
Dr. Lucy Gilbert is a Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. She heads the Tertiary/Quaternary Care Gynecologic Cancer Service of the McGill University Health Centre (MUHC) as well as its Women’s Health Research Unit. Her research focuses on novel therapeutic options for the treatment of ovarian and uterine cancers as well as technologies for their early detection. She has set up a network of satellite clinics as part of the DOvEE (Diagnosing Ovarian and Endometrial Cancers Early) project, which provide open access investigations for women with symptoms associated with gynecologic cancers. She and her team have recently developed an innovative genomic uterine pap-test called DOvEEgene to detect these cancers before they cause symptoms. The test will be offered to women 45-70 years old in the form of a clinical trial starting in May 2021.
Anne Mellon, RN
Clinical Nurse Consultant, Gynaecological Oncology, Hunter New England Centre for Gynaecological Cancer; Stream Leader Women’s Health and Gynaecology, Hunter New England WHAM Network
Anne Mellon is the Clinical Nurse Consultant in Gynaecological Oncology at the Hunter New England Centre for Gynaecological Cancer in Newcastle, NSW, Australia, a position she has held for the past 25 years. Anne is passionate about the care of women with Gynaecological Cancer and has a particular interest in endometrial cancer, vulval cancer and lymphoedema. Anne is a member of many Gynaecological Cancer advisory groups providing high level expert advice to inform the promotion of best practice gynaecological cancer care and improving gynaecological cancer outcomes. She has had a long involvement with the Cancer Nurses Society of Australia, and is a current Board Director, as well as Chair of the Gynaeoncology Specialist Practice Network.
Brian Slomovitz, MD
Gynecologic Oncologist
Professor of Gynecology and Obstetrics, Florida International University

A specialist in clinical trial development, robotic surgery, sentinel lymph node evaluation, and immunotherapy, Dr. Brian Slomovitz is a gynecologic oncologist at Broward Health in Fort Lauderdale, Florida and a Professor of Obstetrics and Gynecology at Florida International University.

Dr. Slomovitz is part of the leadership committee at the GOG Foundation where he coordinates the uterine cancer trials. He is also the principal investigator on a number of GOG clinical trials. He authored more than 100 peer-reviewed articles and lectured extensively. In addition, Dr. Slomovitz has been recognized as a Top Doctor by Castle Connolly Medical for the past several years.

Dr. Slomovitz graduated from Rutgers University – New Jersey Medical School, and completed his residency at New York Presbyterian – Cornell Medical Center in 2002. At MD Anderson Cancer Center, he completed a fellowship in gynecologic oncology in 2006. He is board certified in both obstetrics and gynecology and gynecologic oncology.

Alexandra Taylor, MD
Member, IGCS Council
Radiation Oncologist, Royal Marsden Hospital
Chair, London Cancer Alliance Gynaecology Oncology Pathway Group; Member, National Clinical Studies Group for Gynaecological Cancer
Dr. Alexandra Taylor is a Consultant in Clinical Oncology at The Royal Marsden Hospital, London UK specialising in treatment of gynaecological cancer.  She is the IGCS Council radiation oncology representative, co-Chair of the British Gynaecological Cancer Society Guidelines Group and member of the Royal College of Radiologists Group on Artificial Intelligence in Radiotherapy.
Martha Jean Williams
Endometrial Cancer Survivor
Ambassador, Endometrial Cancer Action Network for African Americans (ECANA)

Martha Jean is energized by the beauty, joy, peace, and love that she has come to know! Her work primarily consisted of communications, nonprofit, and education. Above all, she loves serving her community. In this phase of her life, she is pursuing one of her loves, writing! Other activities she enjoys is growing herbs, cooking dishes from around the world and music! It is a privilege to serve! Being an ECANA Ambassador and a Patient Adviser is a wonderful opportunity to serve! To participate in this dialogue of health and well-being is nothing short of amazing! And the timing! My personal goal for 2020 is taking the best possible care of myself using my Lessons Learned!


Joseph Soon-Yau Ng, MD
Member, IGCS Council
Gynecologic Oncologist, National University Cancer Institute, Singapore

Dr Joseph Ng is gynecologic oncologist at the National University Cancer Institute, Singapore.  He also chairs the National University Health System’s Comprehensive Robotic Surgery program which ensures equal access to robotic surgery for all patients who need it. He is also Assistant Professor of Obstetrics and Gynecology at the National University of Singapore.

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Roundtables

Navigating Telehealth/Telemedicine & Embracing Shared Decision Making
Recorded November 21, 2020
Sponsored by GSK

Patient Advocacy & Support in the Backdrop of COVID-19
Recorded June 30, 2020

Gynecologic Cancer Patient Care & Clinical Trials in the Midst of COVID-19
Recorded May 23, 2020
Sponsored by GOG Foundation